Fundraising Fox

Ventaris Surgical

San Carlos, US · Founded 2024 · Delaware corporation · 4 known investors

Biotech

Founders & leadership

SM
Surag MantriExecutive

Board

JKJustin Klein
Justin Kleinin𝕏Board directorCo-Founder and Managing Partner at Vensana Capital
MS
Matthew SprinkelBoard director
AA
Amir AbolfathiBoard director
VG
Varun GuptaBoard director

Investors · 4

Boutique Venture PartnersPalo Alto
Longitude CapitalMenlo Park · $10M – $30M
Neotribe VenturesMenlo Park · $250K – $2M
Vensana Capitalreported · 2 sourcesMinneapolisvia Justin Klein · board

Reported raises · per SEC filings

Form D private placements

$30.7M disclosed across 1 round · 2026

▶$30.7MraisedMar 2026 · 57 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew SprinkelDirector
  • Justin KleinDirector
  • Surag MantriExecutive Officer, Director
  • Amir AbolfathiDirector
  • Varun GuptaDirector
Offering amount
$30.7M
Amount sold
$30.7M
First sale
Jan 2026
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Sparta Biomedical4 shared keywordsSparta Biomedical develops chemically engineered cartilage implants built on its Hyalos hydrogel platform, including Karthyx, an MTP hemiarthroplasty device that combines the cartilage-mimicking hydrogel with a titanium fixation technology. The company targets treatment of joint cartilage degeneration and osteoarthritis through cartilage-like implants for joints such as the great toe.

Companies competing with Ventaris Surgical for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Ventaris Surgical: $30 Million Series A Raised To Develop System For Complete Kidney Stone Treatmentpulse2.com · Jan 2026Ventaris Surgical Raises $30 Million Series A To Transform Kidney Stone Surgerybiopharmaapac.com · Jan 2026Ventaris Surgical Raises $30M in Series A Fundingfinsmes.com · Jan 2026Ventaris Surgical, Inc. Announces $30M Series A to Advance a Next-Generation System for Complete Kidney Stone Treatmentprnewswire.com · Jan 2026Ventaris Surgical Raises $30M Series A to Advance Next-Generation Kidney Stone Treatment System - News Centerg-medtech.com · Jan 2026Ventaris Surgical Secures $30 Million Series A to Modernize Kidney Stone Treatment | NewDecodednewdecoded.com

Frequently asked questions

Who are Ventaris Surgical's investors?
Ventaris Surgical's investors include Boutique Venture Partners, Longitude Capital, Neotribe Ventures, Vensana Capital.
How much funding has Ventaris Surgical raised?
Ventaris Surgical has disclosed $30.7M raised across 1 round.
Where is Ventaris Surgical headquartered?
Ventaris Surgical is headquartered in San Carlos, US.